Showing results (201-210 of 1,671) with videos related to
Sort By:
Pageof 168
Andrologia|October 18, 2021
Leiomyoadenomatoid tumours of the epididymis: A new case report and review of the literatureRoberta Lucianò, Nazario Pio Tenace, Filippo Pederzoli, et al.Current Opinion in Urology|January 1, 2005
Common grounds for erectile dysfunction and coronary artery diseasePiero Montorsi, Paolo M Ravagnani, Stefano Galli, et al.BJU International|July 24, 2009
Secondary neoplasms of the urinary system and male genital organsDoriana Morichetti, Roberta Mazzucchelli, Antonio Lopez-Beltran, et al.European Urology|May 4, 2010
Testosterone measurement in patients with prostate cancerClaude C Schulman, Jacques Irani, Juan Morote, et al.World Journal of Urology|August 10, 2020
Patient-reported outcomes for typical single cheek harvesting vs atypical lingual, labial or bilateral cheeks harvesting: a single-center analysis of more than 800 patientsGuido Barbagli, Marco Bandini, Sofia Balò, et al.European Journal of Nuclear Medicine and Molecular Imaging|March 23, 2010
PSA doubling time for prediction of [(11)C]choline PET/CT findings in prostate cancer patients with biochemical failure after radical prostatectomyGiampiero Giovacchini, Maria Picchio, Vincenzo Scattoni, et al.Contraception|February 6, 2022
Effect on ovarian activity and ovulation inhibition of different oral dosages of levonorgestrelIngrid J M Duijkers, Christine Klipping, Tanja Rautenberg, et al.The Journal of Sexual Medicine|June 29, 2011
A randomized, double-blind, placebo-controlled, parallel study to assess the efficacy and safety of once-a-day tadalafil in men with erectile dysfunction who are naïve to PDE5 inhibitorsFrancesco Montorsi, Antonio Aversa, Ignacio Moncada, et al.The Journal of Urology|November 21, 2012
[11C]choline positron emission tomography/computerized tomography for early detection of prostate cancer recurrence in patients with low increasing prostate specific antigenGiampiero Giovacchini, Maria Picchio, Rita Garcia-Parra, et al.Cancer|May 13, 2022
Adjuvant immunotherapy in patients with high-risk muscle-invasive urothelial carcinoma: The potential impact of informative censoringAlberto Martini, Menggang Yu, Daniele Raggi, et al.Pageof 168